Tasigna capsule 200 mg 28’s

Tasigna 200 mg Capsule contains nilotinib, a targeted cancer therapy used primarily for the treatment of chronic myeloid leukemia (CML). It belongs to a class of medications known as tyrosine kinase inhibitors (TKIs), designed to block cancer cell growth at the molecular level.

What is Tasigna 200 mg Capsule?

Tasigna 200 mg is an oral anti-cancer medication prescribed for patients diagnosed with Philadelphia chromosome-positive (Ph+) CML. It is commonly used in both newly diagnosed patients and those who are resistant or intolerant to other treatments.

Uses of Tasigna 200 mg Capsule

• Treatment of chronic myeloid leukemia (CML)
• Management of Philadelphia chromosome-positive leukemia
• Used in patients resistant to other therapies like imatinib
• Helps control disease progression in chronic and accelerated phases

Benefits of Tasigna 200 mg

• Targets cancer cells with high precision
• Helps achieve faster and deeper molecular response
• Reduces progression of leukemia
• Oral capsule for convenient use
• Effective alternative when other treatments fail

How Tasigna Works

Tasigna (nilotinib) works by inhibiting the BCR-ABL tyrosine kinase enzyme, which is responsible for the uncontrolled growth of leukemia cells. By blocking this signal, it helps stop cancer cell proliferation.

Side Effects of Tasigna 200 mg Capsule

Common Side Effects

• Nausea
• Fatigue
• Headache
• Rash
• Constipation

Serious Side Effects

• Heart rhythm problems (QT prolongation)
• Liver dysfunction
• Pancreatitis
• Low blood cell counts
• Sudden cardiac events (rare but serious)

Precautions & Warnings

• Must be taken on an empty stomach
• Regular monitoring of ECG and liver function required
• Avoid in patients with heart rhythm disorders
• Not recommended during pregnancy or breastfeeding
• Inform your doctor about all medications to avoid interactions

Dosage & Administration

• Usually taken twice daily
• Take capsules at least 2 hours after food and 1 hour before next meal
• Follow doctor’s prescription strictly

Packaging Information

• Pack size: 28 capsules
• Designed for continuous leukemia management

Conclusion

Tasigna 200 mg Capsule (28’s) is a highly effective targeted therapy for chronic myeloid leukemia. With proper monitoring and adherence, it offers significant control over disease progression and improves patient outcomes.

SEO Keywords / Hashtags